Affluent Medical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Sebastien Ladet
Chief executive officer
€279.0k
Total compensation
| CEO salary percentage | 77.1% |
| CEO tenure | 1.9yrs |
| CEO ownership | 1.0% |
| Management average tenure | 1.3yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -€17m |
| Mar 31 2024 | n/a | n/a | -€16m |
| Dec 31 2023 | €279k | €215k | -€16m |
| Sep 30 2023 | n/a | n/a | -€15m |
| Jun 30 2023 | n/a | n/a | -€15m |
| Mar 31 2023 | n/a | n/a | -€15m |
| Dec 31 2022 | €502k | €77k | -€15m |
Compensation vs Market: Sebastien's total compensation ($USD301.19K) is below average for companies of similar size in the German market ($USD483.75K).
Compensation vs Earnings: Sebastien's compensation has been consistent with company performance over the past year.
CEO
Sebastien Ladet
1.9yrs
Tenure
€278,962
Compensation
Sebastien Ladet, Ph D., is Chief Executive Officer of Affluent Medical SA from August 2022. Sebastien Ladet was Former Senior R&D Director – Technology Strategy and Innovation of the Surgical Innovation Bu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.9yrs | €278.96k | 0.96% € 680.0k | |
| Chief Financial Officer | 1.3yrs | no data | no data | |
| Marketing Director | no data | no data | no data | |
| Human Resources Manager | 1.3yrs | no data | no data | |
| Chief Surgical Officer | no data | no data | no data | |
| Deputy Chief Executive Officer | no data | no data | no data | |
| Chief Development Officer | 1.5yrs | no data | no data | |
| Chief Medical Officer & VP of Clinical Affairs | 1.3yrs | no data | no data |
1.3yrs
Average Tenure
Experienced Management: 0JZ's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.